SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Molecular Diagnostics

• Publication date

  2015-10-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1586/14737159.2015.1093937PMID 26472065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of proteins in urine samples using targeted mass spectrometry methods.

  2015influential reference
• CE‐MS‐based proteomics in biomarker discovery and clinical application

  2015cited by this paper
• The fickle P value generates irreproducible results

  2015cited by this paper
• Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS

  2015cited by this paper
• Historical perspectives in clinical pathology: a history of glucose measurement

  2015cited by this paper
• Inconvenient truth: cancer biomarker development by using proteomics.

  2014cited by this paper
• MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments

  2014cited by this paper
• Absolute quantification of podocin, a potential biomarker of glomerular injury in human urine, by liquid chromatography-multiple reaction monitoring cubed mass spectrometry.

  2014cited by this paper
• Urinary Protein Biomarker Panel for the Detection of Recurrent Bladder Cancer

  2014cited by this paper
• Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.

  2014cited by this paper
• Multiplexed LC-MS/MS assay for urine albumin.

  2014cited by this paper
• A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum.

  2014cited by this paper
• Development of quantitative method for determination of γ-glutamyl peptides by capillary electrophoresis tandem mass spectrometry: an efficient approach avoiding matrix effect.

  2014cited by this paper
• Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).

  2014cited by this paper
• External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort

  2014cited by this paper
• Simultaneous multi-analyte urinary protein assay for bladder cancer detection

  2014cited by this paper
• Dipping your feet in the water: podocytes in urine

  2014cited by this paper
• Western Blots versus Selected Reaction Monitoring Assays: Time to Turn the Tables?

  2013cited by this paper
• Capillary zone electrophoresis-multiple reaction monitoring from 100 pg of RAW 264.7 cell lysate digest.

  2013cited by this paper
• The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients.

  2013cited by this paper
• A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

  2013cited by this paper
• Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications

  2013cited by this paper
• Targeted Quantitation of Proteins by Mass Spectrometry

  2013cited by this paper
• Molecular diagnosis of prostate cancer: are we up to age?

  2013cited by this paper
• Optimization of liquid chromatography-multiple reaction monitoring cubed mass spectrometry assay for protein quantification: application to aquaporin-2 water channel in human urine.

  2013cited by this paper
• Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms.

  2013cited by this paper
• A Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules

  2013cited by this paper
• The current status of clinical proteomics and the use of MRM and MRM3 for biomarker validation

  2012cited by this paper
• Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

  2012cited by this paper
• Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

  2012cited by this paper
• Differential Proteome Profiling Using iTRAQ in Microalbuminuric and Normoalbuminuric Type 2 Diabetic Patients

  2012cited by this paper
• Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics

  2012cited by this paper
• A Computational Tool to Detect and Avoid Redundancy in Selected Reaction Monitoring

  2012cited by this paper
• Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.

  2012influential reference
• CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer

  2012cited by this paper
• Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum

  2012cited by this paper
• Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.

  2012cited by this paper
• Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness*

  2011cited by this paper
• Toward a standardized urine proteome analysis methodology

  2011cited by this paper
• Systematic quantification of peptides/proteins in urine using selected reaction monitoring

  2011influential reference
• Global cancer statistics

  2011cited by this paper
• Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease.

  2011cited by this paper
• Native antigen fractionation protein microarrays for biomarker discovery.

  2011cited by this paper
• Computational Mass Spectrometry–Based Proteomics

  2011cited by this paper
• ATAQS: A computational software tool for high throughput transition optimization and validation for selected reaction monitoring mass spectrometry

  2011cited by this paper
• Methods for Peptide and Protein Quantitation by Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry*

  2011cited by this paper
• [Current issues in measurement and reporting of urinary albumin excretion].

  2010cited by this paper
• Comprehensive human urine standards for comparability and standardization in clinical proteome analysis

  2010cited by this paper
• Mass spectrometry in high-throughput proteomics: ready for the big time

  2010cited by this paper
• The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification.

  2010cited by this paper
• Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome.

  2010cited by this paper
• Verification of biomarkers for diabetic retinopathy by multiple reaction monitoring.

  2010cited by this paper
• Urine albumin-to-creatinine ratio: what's in a number?

  2010cited by this paper
• CEBP Focus: Biomarkers and Biospecimens

  2010cited by this paper
• An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers*

  2009cited by this paper
• MRMaid, the Web-based Tool for Designing Multiple Reaction Monitoring (MRM) Transitions*

  2009cited by this paper
• Statistical design of quantitative mass spectrometry-based proteomic experiments.

  2009cited by this paper
• Urinary calreticulin in the diagnosis of bladder urothelial carcinoma

  2009cited by this paper
• Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean.

  2009cited by this paper
• Current issues in measurement and reporting of urinary albumin excretion.

  2009cited by this paper
• Urine proteomics for profiling of human disease using high accuracy mass spectrometry

  2009cited by this paper
• The Proteomics Identifications database: 2010 update

  2009cited by this paper
• Comparative Evaluation of Current Peptide Production Platforms Used in Absolute Quantification in Proteomics*S

  2008cited by this paper
• Urine in Clinical Proteomics*

  2008cited by this paper
• Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice.

  2008cited by this paper
• The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine.

  2008cited by this paper
• PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows

  2008cited by this paper
• Biomarkers of acute kidney injury.

  2008cited by this paper
• Computational prediction of proteotypic peptides for quantitative proteomics

  2007cited by this paper
• Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis.

  2007cited by this paper
• Urine proteomics: the present and future of measuring urinary protein components in disease

  2007cited by this paper
• Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S

  2007cited by this paper
• Novel Blood Biomarkers of Human Urinary Bladder Cancer

  2006cited by this paper
• Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

  2006cited by this paper
• A List of Candidate Cancer Biomarkers for Targeted Proteomics

  2006cited by this paper
• The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins

  2006cited by this paper
• PRIDE: The proteomics identifications database

  2005cited by this paper
• Open source system for analyzing, validating, and storing protein identification data.

  2004cited by this paper
• Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

  2004cited by this paper
• Acute-phase proteins and microalbuminuria among patients with type 2 diabetes.

  2004cited by this paper
• Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.

  2003cited by this paper
• Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence.

  2002cited by this paper
• Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments

  year unknowncited by this paper

• Nuevas fronteras en la oncología de precisión: la transcriptómica y la proteómica

  2026cites this paper
• Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based Detection.

  2026cites this paper
• SPR biosensing: Cancer diagnosis and biomarkers quantification

  2024cites this paper
• ProPickML: Advancing Clinical Diagnostics with Automated Peak Picking in Label-Free Targeted Proteomics

  2024cites this paper
• Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease

  2024cites this paper
• Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing

  2024cites this paper
• LC-MS/MS-Based Absolute Quantitation of Hemoglobin Subunits from Dried Blood Spots Reveals Novel Biomarkers for α-Thalassemia Silent Carriers.

  2023cites this paper
• A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors

  2023cites this paper
• Mass spectrometry-based proteomics as an emerging tool in clinical laboratories

  2023cites this paper
• Shotgun Proteomics of Co-Cultured Leukemic and Bone Marrow Stromal Cells from Different Species as a Preliminary Approach to Detect Intercellular Protein Transfer

  2023cites this paper
• Proteomics in Inherited Metabolic Disorders

  2022cites this paper
• Clinical application of serum-based proteomics technology in human tumor research.

  2022cites this paper
• Targeted Proteomics for Monitoring One-Carbon Metabolism in Liver Diseases

  2022cites this paper
• Surrogate peptide selection and internal standardization for accurate quantification of endogenous proteins.

  2022cites this paper
• Effective Diagnosis of Prostate Cancer Based on mRNAs From Urinary Exosomes

  2022cites this paper
• Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers

  2022cites this paper
• Targeted liquid chromatography‐tandem mass spectrometry analysis of proteins: Basic principles, applications, and perspectives

  2021cites this paper
• Development of a multiplex mass spectrometry method for simultaneous quantification of urinary proteins related to respiratory health

  2021cites this paper
• Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm

  2021cites this paper
• Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer Progression

  2021cites this paper
• Needle lost in the haystack: multiple reaction monitoring fails to detect Treponema pallidum candidate protein biomarkers in plasma and urine samples from individuals with syphilis [version 2; peer review: 2 approved]

  2020cites this paper
• Novel biomarkers in cats with congestive heart failure due to primary cardiomyopathy.

  2020cites this paper
• Profiling tear proteomes of patients with unilateral relapsed Behcet’s disease-associated uveitis using data-independent acquisition proteomics

  2020cites this paper
• Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma

  2020cites this paper
• Development and Validation of Multiple Reaction Monitoring (MRM) Assays for Clinical Applications.

  2019cites this paper
• Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer

  2019cites this paper
• Applications of multiple reaction monitoring targeted proteomics assays in human plasma

  2019cites this paper
• Promise and Implementation of Proteomic Prostate Cancer Biomarkers

  2018cites this paper
• Biomarkers of Duchenne muscular dystrophy: current findings

  2018cites this paper
• Clinical Proteomics: Closing the Gap from Discovery to Implementation

  2018cites this paper
• On-Line Solid Phase Extraction Liquid Chromatography-Mass Spectrometry Method for Multiplexed Proteins Quantitation in an Ecotoxicology Test Specie: Gammarus fossarum

  2018influential citation
• Quantitation of peptides from non-invasive skin tapings using isotope dilution and tandem mass spectrometry.

  2018cites this paper
• Insights into apoptotic proteins in chemotherapy: quantification techniques and informing therapy choice

  2018cites this paper
• Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease

  2018cites this paper
• Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine

  2018cites this paper
• Needle lost in the haystack: multiple reaction monitoring fails to detect Treponema pallidum candidate protein biomarkers in plasma and urine samples from individuals with syphilis

  2018cites this paper
• Quantification of Cardiovascular Disease Biomarkers in Human Platelets by Targeted Mass Spectrometry

  2017influential citation
• Exploratory biomarkers: Analytical approaches and their implications

  2017cites this paper
• Identification of temperature regulated factors of Campylobacter jejuni and their potential roles in virulence

  2017cites this paper
• Current trends in quantitative proteomics - an update.

  2017cites this paper
• Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay‐based validation

  2017cites this paper
• MiR‐145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method

  2017cites this paper
• Breaking the ice: urine proteomics of medullary sponge kidney disease.

  2017cites this paper
• Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism

  2016cites this paper
• Assess of catechol-O-methyltransferase soluble isoform by multiple reaction monitoring mass spectrometry

  2016influential citation
• Urinary biomarkers for renal tract malformations

  2016cites this paper
• Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease

  2016cites this paper
• The biochemistry of blister fluid from pediatric burn injuries: proteomics and metabolomics aspects

  2016cites this paper
• Mass Spectrometry: Structure Determination of Proteins and Peptides

  2013cites this paper
• Hematología y Oncología

  year unknowncites this paper
• Identification of differentially temperature regulated virulence factors of Campylobacter jejuni and tested in Galleria mellonella

  year unknowncites this paper